Financials

  • Market Capitalization 2.46 B
  • Employee 361
  • Founded 2016
  • CEO N/A
  • Website www.veratx.com
  • Headquarter Delaware, United States
  • FIGI BBG00Q72WYG3
  • Industry Biotecnologia
Ricavi totali
Utile netto
Utile base per azione (EPS base)
Debito totale
Liquidità libera
Disponibilità liquide e mezzi equivalenti
Rapporto prezzo/utili
-7.32
Rapporto prezzo/fatturato
-2 874.39

Related tickers

#NomePrezzo24h %7d %1M %1Y %Valore di MercatoUltimi 7 Giorni
1857
PGEN
Precigen, Inc. - Common Stock
6.95 USD-3.34%-2.80%+17.00%+54.79%2.49 B USD
1862
NKTR
Nektar Therapeutics - Common Stock
72.52 USD-2.72%-0.67%+2.37%-1.02%2.48 B USD
1880
TRVI
Trevi Therapeutics, Inc. - Common Stock
16.79 USD-6.51%-4.60%-9.19%+134.83%2.39 B USD
1885
KOD
Kodiak Sciences Inc - Common Stock
37.72 USD-3.58%-2.05%-11.14%+326.21%2.37 B USD

Notizie